Patent holdings for IPC class C12N 15/113

Total number of patents in this class: 29124

10-year publication summary

1542
1561
1731
1998
1968
2282
2370
2573
2788
2675
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Alnylam Pharmaceuticals, Inc.
1140
732
Ionis Pharmaceuticals, Inc.
919
608
The Regents of the University of California
20303
581
University of Massachusetts
2263
410
Massachusetts Institute of Technology
10150
280
President and Fellows of Harvard College
6043
246
Regeneron Pharmaceuticals, Inc.
4453
219
Inserm (institut National de La Sante et de La Recherche Medicale)
3374
213
The Broad Institute, Inc.
1875
210
Arrowhead Pharmaceuticals, Inc.
321
209
The General Hospital Corporation
4801
199
The Board of Trustees of the Leland Stanford Junior University
6541
176
Centre National de La Recherche Scientifique
10706
174
Hoffmann-La Roche Inc.
3546
158
Monsanto Technology LLC
8273
153
Sarepta Therapeutics, Inc.
382
153
Institut National de La Sante et de La Recherche Medicale (inserm)
3003
140
Dicerna Pharmaceuticals, Inc.
200
139
Board of Regents, The University of Texas System
5946
138
The Trustees of the University of Pennsylvania
4390
133
Other owners 23853